Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-11-28Clinical Trial Update: THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS
This clinical trial update reports on an ongoing study examining the association between polycystic ovary syndrome and nonalcoholic fatty li…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) [Phase 3]
TONIC is a Phase 3 clinical trial evaluating treatments for pediatric nonalcoholic fatty liver disease; the study is completed with results …
-
CLINICAL_TRIALS research · 2012-09-27Clinical Trial Update: Telomere Parameters in Patients With Nonalcoholic Fatty Liver
Clinical trial update reporting on telomere parameter studies in patients with nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls
A completed clinical trial evaluating glucose-induced GLP-1 secretion in patients with NAFLD/NASH compared with healthy controls.
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm
A completed clinical trial examined the association between nonalcoholic fatty liver disease and colorectal cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease [Phase 2]
This update discusses a Phase 2 trial evaluating the roles of pioglitazone and berberine in treating nonalcoholic fatty liver disease, which…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Dietary Protein and Hepatic Fat Accumulation [NA]
This update notes that a clinical trial investigating dietary protein's effect on hepatic fat accumulation, including nonalcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus [Phase 4]
Phase 4 clinical trial evaluating initial treatment of significant fatty liver with Xenical (orlistat) followed by Hepatitis C therapy with …
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 study of Aramchol in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial evaluating spironolactone and vitamin E for nonalcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Effects of a Low Glycemic Load Diet on Fatty Liver in Children [NA]
A completed clinical trial evaluated whether a low glycemic load diet can improve hepatic steatosis (fatty liver) in children.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 1, Phase 2]
This completed Phase 1/2 trial assessed the effects of docosahexaenoic acid (DHA) supplementation in children with nonalcoholic fatty liver …
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease
A clinical trial update examining whether lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to the presence of coronary p…
-
CLINICAL_TRIALS research · 2010-12-24Clinical Trial Update: Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
This completed clinical trial assesses the prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis using ultrasound …
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 4]
Phase 4 trial results assess the effects of exenatide (Byetta) on liver function in patients with nonalcoholic steatohepatitis (NASH); the s…
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD) [Phase 1]
Phase 1 trial results assessing the safety and initial efficacy signals of Hoodia Gordonii for treatment of nonalcoholic fatty liver disease…
-
CLINICAL_TRIALS trial_result · 2010-09-17Clinical Trial Update: Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease [Phase 1, Phase 2]
Clinical trial evaluating bovine colostrum for nonalcoholic fatty liver disease (NASH/NAFLD). The study completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
This clinical trial update reports the completion of a Magnetic Resonance Spectroscopy validation study in individuals with nonalcoholic fat…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
This clinical trial update summarizes Phase 1/2 results for an insulin sensitizer used to evaluate effects on arterial properties, metabolic…
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Pioglitazone to Treat Fatty Liver in People With HIV Infection [Phase 2]
Phase 2 study evaluating pioglitazone for hepatic steatosis in people with HIV was completed, and results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Weight Management in Nonalcoholic Steatohepatitis [Phase 2]
An update on a Phase 2 weight-management trial for Nonalcoholic Steatohepatitis (sponsored by NIDDK). The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2009-06-19Clinical Trial Update: Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial comparing rosiglitazone alone vs rosiglitazone with metformin vs rosiglitazone with Avandia for nonalcoholic steatohepatitis a…
-
CLINICAL_TRIALS research · 2009-04-27Clinical Trial Update: Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
This document describes a clinical trial update investigating molecular aspects of nonalcoholic fatty liver disease in obese patients.
-
CLINICAL_TRIALS research · 2008-04-30Clinical Trial Update: Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis [Phase 4]
Phase 4 clinical trial update evaluating losartan and simvastatin in hypertensive obese patients with liver steatosis; status information is…
-
CLINICAL_TRIALS research · 2008-04-14Clinical Trial Update: Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores [Phase 3]
A Phase 3 clinical trial examines whether iron depletion by phlebotomy plus lifestyle changes improves liver damage compared with lifestyle …